Biome Australia Ltd (AU:BIO) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Biome Australia Ltd has announced that they anticipate a record-breaking first quarter in FY25, with sales revenue expected to exceed $4.0 million. This follows the previous quarter’s high of $3.8 million, signaling ongoing growth for the company that specializes in probiotics and complementary medicines aimed at improving health outcomes. Biome’s products, which are backed by clinical research, cater to various health concerns and are distributed both locally and internationally.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.